What Will It Take to Make Cost-Effectiveness Analysis Acceptable in the United States
Bibliographic Data
| ID | 9100455 |
|---|---|
| Authors | Bryan R Luce (United BioSource Corporation (United Kingdom), corresponding author) |
| Year | 2005 |
| Volume | 43 |
| Issue | 7 |
| Pages | II-44 |
| Publication date | 2005-07-01 |
| Open Access | No |
| Type | ARTICLE |
| Venue | Medical Care (JOURNAL) |
| Journal identifiers | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Publisher | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/01.mlr.0000170054.26616.29 |
| PMID | 16056008 |
| OpenAlex | W2088952228 |
| Language | EN |
| Citations received | 4 |
| References cited | 7 |
Many believe cost-effectiveness analysis (CEA) to be an underused tool to assist healthcare decision-makers. Reasons given for its underuse have largely focused on unstandardized methods, potential for bias, lack of training particularly among potential consumers of studies, and lack of trust between sponsors and users of analyses. This commentary reflects on these and related issues, including legal and political constraints. It discounts many of the conventional arguments regarding the real obstacles to using CEA and suggests steps needed to make CEA more acceptable to US healthcare decision-makers
Business · Cost–benefit analysis · Decision analysis · Economics · Health care · Management science · Political science · Politics · Risk analysis (engineering) · Computer Science · Health Systems, Economic Evaluations, Quality of Life · Healthcare cost, quality, practices · Law · Pharmaceutical Economics and Policy
Cost-Effectiveness in Health and Medicine
Common Methodological Flaws in Economic Evaluations
The Arrival of Economic Evidence in Managed Care Formulary Decisions
Incorporating Economic Evaluations Into Decision-Making
The Evolving Use of Cost-Effectiveness Analysis in Formulary Management Within the Department of Veterans Affairs
Incorporating Information About Cost-Effectiveness Into Evidence-Based Decision-Making
| Citations per year | 0.19 |
|---|---|
| Citation span | 2005 - 2009 (5) |
| Highly cited | No |